Has John Schindler, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,048 in general payments to John Schindler, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Schindler, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Schindler, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Schindler, MD

Interventional Cardiology · Gastonia, NCNPI 1508831546

Payments from drug & device makers

What this record shows

12 manufacturers reported payments, led by Edwards Lifesciences at 31.5% of the total. Reporting peaked in 2019 at $3,897 and has fallen 61.1% since, to $1,515 in 2025.

$12,048in general payments, 2019–2025

Across 143 payments — averaging $84.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$4K
Medtronic$3K
Abbott$2K
Boston Scientific$2K
Abiomed$328
Heartflow, Inc.$193
plus $389 from 6 others

$59,028in research payments, 2019–2025

Across 24 payments — averaging $2459.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Boston Scientific$59K

What the payments were for

Travel & lodging$5,34744%
Food & beverage$6,70156%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	55	$3,792
Medtronic(2 entities)	34	$3,342
Abbott	17	$2,390
Boston Scientific	23	$1,616
Abiomed	5	$328
Heartflow, Inc.	2	$193
Biosense Webster, Inc.	2	$179
Inari Medical, Inc.	1	$124
Shockwave Medical, Inc	1	$24
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$22
Terumo Medical Corporation	1	$21
Cardiva Medical, Inc.	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$2,565
CoreValve Evolut$2,307
MitraClip$1,537
AVVIGO Guidance System$545
COREVALVE EVOLUT R$274
WATCHMAN Access System$251
XIENCE SKYPOINT$178
Xience Sierra Coronary Stent System$164
WATCHMAN FLX$163
CARDIOMEMS$150
Carto 3$144
PASCAL$143
FLOWTRIEVER CATHETER, S$124
CT THROMBECTOMY SYSTEM KIT$124
FFRct$117
CG Future$115
Watchman$107
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$106

How this compares

$12,048 in reported general payments places this provider in the 70th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$119,976

Medicare patients

299

Services billed

894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	179	$176,193
JardianceEmpagliflozin	18	$24,659
XareltoRivaroxaban	14	$12,289
VascepaIcosapent Ethyl	12	$7,506
ClopidogrelClopidogrel Bisulfate	141	$1,165
Losartan Potassium	101	$979
Metoprolol Succinate	101	$858
Atorvastatin Calcium	92	$654
Rosuvastatin Calcium	80	$624
Amlodipine Besylate	80	$454
Potassium Chloride	33	$396
Ezetimibe	33	$393
Furosemide	71	$368
Amiodarone Hcl	16	$279
Carvedilol	34	$274

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Gastonia

George AdamsGarner$4.1M
Paul MahoneyGreenville$1.7M
Ravish SacharRaleigh$1.6M
Patrick SimpsonPinehurst$579K
Ronald UszenskiMooresville$495K
Oluseun AlliCharlotte$485K
Matthew CavenderChapel Hill$453K
Steven FilbyPinehurst$442K
Naveed RajperStatesville$223K
Siddhartha RaoCary$223K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →